Last10K.com

Nuvectra Corp (NVTR) SEC Filing 8-K Material Event for the period ending Friday, September 14, 2018

Nuvectra Corp

CIK: 1648893 Ticker: NVTR

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 OR 15 (d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): September 14, 2018

 


 

Nuvectra Corporation

(Exact Name of Issuer as Specified in Charter)

 


 

Delaware

 

001-37525

 

30-0513847

(State or Other Jurisdiction of
Incorporation or Organization)

 

(Commission
File Number)

 

(I.R.S. Employer
Identification No.)

 

5830 Granite Parkway, Suite 1100,

Plano, Texas 75024

(Address of Principal Executive Offices)

 

(214) 474-3103

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former name or former address, if changed since last report)

 

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 8.01     Other Events.

 

On September 14, 2018, Nuvectra Corporation issued a press release announcing the closing of its underwritten follow-on public offering of 3,248,750 shares of its common stock at a price to the public of $21.25 per share, which included the exercise in full by the underwriters of their option to purchase 423,750 additional shares of common stock. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01     Financial Statements and Exhibits.

 

Exhibit
No.

 

Document

 

 

 

99.1

 

Press Release dated September 14, 2018.

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 14, 2018

 

 

NUVECTRA CORPORATION

 
     

 

 

 

 
       

 

By:

/s/ Walter Z. Berger

 

 

 

Name: Walter Z. Berger

 

 

 

Title: Chief Operating Officer and Chief Financial Officer

 

 

3

 

 

EXHIBIT INDEX

 

Exhibit
No.

 

Document

 

 

 

99.1

 

Press Release dated September 14, 2018.

 

4

 

View differences made from one to another to evaluate Nuvectra Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nuvectra Corp.

Continue

Assess how Nuvectra Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nuvectra Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Nuvectra Corp provided additional information to their SEC Filing as exhibits

Ticker: NVTR
CIK: 1648893
Form Type: 8-K Corporate News
Accession Number: 0001437749-18-017029
Submitted to the SEC: Fri Sep 14 2018 12:06:29 PM EST
Accepted by the SEC: Fri Sep 14 2018
Period: Friday, September 14, 2018
Industry: Surgical And Medical Instruments And Apparatus
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/nvtr/0001437749-18-017029.htm